FDA 483 - Sun Pharmaceutical Industries Ltd. - November 08, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sun Pharmaceutical Industries Ltd. in Baruch, Gujarat, India, received a Form 483 for significant deficiencies in their API manufacturing operations. Observations included inadequate written procedures for testing leading to potential data integrity issues, insufficient investigation and documentation of Out-of-Specification results, and incomplete investigations of quality-related complaints. These issues indicate a lack of robust quality control and data management practices.
ID · 1b76acf1-0cc6-46a8-bd3d-14c1d7bed7a9